Editorial: Protease inhibitors
โ Scribed by Yoshiaki Kiso
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 1999
- Tongue
- English
- Weight
- 11 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Thrombin and factor Xa (fXa) are the only serine proteases for which small, potent, selective, noncovalent inhibitors have been developed, which are ultimately intended as drug development candidates (in this case as anticoagulants). Noncovalent inhibitors may be more selective and chemically and me
## Background: Squamous cell carcinoma of the esophagus is endemic in parts of south africa. previous case-control studies have shown many associations but no clear etiologic pathway has been established. ## Methods: A case-control study of dietary and social factors was performed for 130 patient
We are interested in modeling enzymeแinhibitor interactions with a view to improve the understanding of the biology of these processes. The present work focuses, therefore, on the research on enzymeแinhibitor interactions using two highly homologous enzymes as our models: โค-factor XIIa and trypsin.